MANNKIND CORP Tax Withholding Paid on Stock Awards
MANNKIND CORP (MNKD) reported Tax Withholding Paid on Stock Awards of $325.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2020-05-06
- MANNKIND CORP payment, tax withholding, share-based payment arrangement for the quarter ending 2020-03-31 was $325.00K.
- MANNKIND CORP payment, tax withholding, share-based payment arrangement for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- MANNKIND CORP payment, tax withholding, share-based payment arrangement for the quarter ending 2018-06-30 was $103.00K, a 692.31% increase year-over-year.
- MANNKIND CORP payment, tax withholding, share-based payment arrangement for the quarter ending 2018-03-31 was $81.00K, a 8.00% increase year-over-year.
- MANNKIND CORP payment, tax withholding, share-based payment arrangement for fiscal 2017 was $127.00K, a 23.03% decline from fiscal 2016.
- MANNKIND CORP payment, tax withholding, share-based payment arrangement for fiscal 2016 was $165.00K, a 91.12% decline from fiscal 2015.
- MANNKIND CORP payment, tax withholding, share-based payment arrangement for fiscal 2015 was $1.86M, a 93.09% decline from fiscal 2014.
- MANNKIND CORP payment, tax withholding, share-based payment arrangement for fiscal 2014 was $26.91M, a 460.47% increase from fiscal 2013.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month | Payment, Tax Withholding, Share-based Payment Arrangement 277 month | Payment, Tax Withholding, Share-based Payment Arrangement 280 month | Payment, Tax Withholding, Share-based Payment Arrangement 283 month |
|---|---|---|---|---|---|---|---|
| 2020-03-31 | $325.00K 10-Q · filed 2020-05-06 | ||||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $103.00K derived: sum of 2 quarters · filed 2019-11-08 | $184.00K 10-Q · filed 2019-11-08 | $201.00K derived: sum of 4 quarters · filed 2019-11-08 | |||
| 2018-06-30 | $103.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $184.00K 10-Q · filed 2019-08-07 | $201.00K derived: sum of 3 quarters · filed 2019-08-07 | $223.00K derived: sum of 4 quarters · filed 2019-08-07 | |||
| 2018-03-31 | $81.00K 10-Q · filed 2019-05-07 | $98.00K derived: sum of 2 quarters · filed 2019-05-07 | $120.00K derived: sum of 3 quarters · filed 2019-05-07 | $133.00K derived: sum of 4 quarters · filed 2019-05-07 | |||
| 2017-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $39.00K derived: sum of 2 quarters · filed 2019-02-26 | $52.00K derived: sum of 3 quarters · filed 2019-02-26 | $127.00K 10-K · filed 2019-02-26 | |||
| 2017-09-30 | $22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $35.00K derived: sum of 2 quarters · filed 2018-11-01 | $110.00K 10-Q · filed 2018-11-01 | $114.00K derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $88.00K 10-Q · filed 2018-08-02 | $92.00K derived: sum of 3 quarters · filed 2019-02-26 | $250.00K derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | $75.00K 10-Q · filed 2018-05-09 | $79.00K derived: sum of 2 quarters · filed 2019-02-26 | $237.00K derived: sum of 3 quarters · filed 2019-02-26 | $237.00K derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $162.00K derived: sum of 2 quarters · filed 2019-02-26 | $162.00K derived: sum of 3 quarters · filed 2019-02-26 | $165.00K 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $158.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $158.00K derived: sum of 2 quarters · filed 2017-11-07 | $161.00K 10-Q · filed 2017-11-07 | $186.00K derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $3.00K 10-Q · filed 2017-08-07 | $28.00K derived: sum of 3 quarters · filed 2018-02-27 | $1.04M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | $3.00K 10-Q · filed 2017-05-10 | $28.00K derived: sum of 2 quarters · filed 2018-02-27 | $1.04M derived: sum of 3 quarters · filed 2018-02-27 | $1.10M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $1.04M derived: sum of 2 quarters · filed 2018-02-27 | $1.10M derived: sum of 3 quarters · filed 2018-02-27 | $1.86M 10-K · filed 2018-02-27 | |||
| 2015-09-30 | $1.01M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-09 | $1.07M derived: sum of 2 quarters · filed 2016-11-09 | $1.83M 10-Q · filed 2016-11-09 | $1.90M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | $56.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2016-08-10 | $818.00K 10-Q/A · filed 2016-08-10 | $882.00K derived: sum of 3 quarters · filed 2017-03-16 | $27.60M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-03-31 | $762.00K 10-Q · filed 2016-05-09 | $826.00K derived: sum of 2 quarters · filed 2017-03-16 | $27.55M derived: sum of 3 quarters · filed 2017-03-16 | $27.64M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | $64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $26.79M derived: sum of 2 quarters · filed 2017-03-16 | $26.88M derived: sum of 3 quarters · filed 2017-03-16 | $26.91M 10-K · filed 2017-03-16 | |||
| 2014-09-30 | $26.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $26.81M derived: sum of 2 quarters · filed 2015-11-09 | $26.84M 10-Q · filed 2015-11-09 | $29.55M derived: sum of 4 quarters · filed 2016-03-15 | $44.67M 10-Q · filed 2014-11-10 | ||
| 2014-06-30 | $90.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $123.00K 10-Q · filed 2015-08-10 | $2.83M derived: sum of 3 quarters · filed 2016-03-15 | $4.48M derived: sum of 4 quarters · filed 2016-03-15 | $17.95M 10-Q · filed 2014-08-11 | ||
| 2014-03-31 | $33.00K 10-Q · filed 2015-05-11 | $2.74M derived: sum of 2 quarters · filed 2016-03-15 | $4.39M derived: sum of 3 quarters · filed 2016-03-15 | $4.41M derived: sum of 4 quarters · filed 2016-03-15 | $17.86M 10-Q · filed 2014-05-12 | ||
| 2013-12-31 | $2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $4.35M derived: sum of 2 quarters · filed 2016-03-15 | $4.37M derived: sum of 3 quarters · filed 2016-03-15 | $4.80M 10-K · filed 2016-03-15 | |||
| 2013-09-30 | $1.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $1.67M derived: sum of 2 quarters · filed 2014-11-10 | $2.10M 10-Q · filed 2014-11-10 | ||||
| 2013-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $448.00K 10-Q · filed 2014-08-11 | |||||
| 2013-03-31 | $427.00K 10-Q · filed 2014-05-12 | ||||||
| 2012-12-31 | $906.00K 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |